State-of-the-Art in Combination Immuno/Radiotherapy for Non-Small Cell Lung Cancer
Webinar | English | 1 Hr 13 Min
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
This webinar will explore the expected benefits, toxicities and potential indications for the combination of immunotherapy and radiotherapy. Both are often used in the care of patients with non-small cell lung cancer, typically with non-overlapping indications for use. Topics will include the preclinical and clinical evidence and rationale for combining radiotherapy and immunotherapy.
This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.
Upon completion of this activity, the participants should be able to: 
  • Understand the preclinical rationale for synergy in combining radiotherapy and immunotherapy.
  • Understand the unresolved questions around sequencing, dose/fractionation, abscopal effects, and sites of irradiation in combination therapy.
  • Understand pertinent clinical trial evidence for the safety and efficacy of radiotherapy and immunotherapy combinations.
  • Update key ongoing trials of RT-IO combo in the curative, oligometastatic and metastatic setting.
Faculty and Planners
  • Corinne Faivre-Finn, FRCR ,MD, PhD
  • Shankar Siva, MBBS, FRANZCR, PhD
  • Willemijn S.M.E. Theelen, MD, PhD
  • Kirsten Black, PhD, MPH
  • Aubrey Shoe, MA

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.
Powered By